Back

Notification report


Full notification file


General information

Notification Number
B/NL/20/001

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
19/02/2020

Title of the Project
Clinical testing of TX200-TR101, an autologous antigen-specific chimeric antigen receptor (CAR) T regulatory cell therapy.

Proposed period of release:
01/03/2020 to 31/12/2041

Name of the Institute(s) or Company(ies)
Sangamo Therapeutics France SAS, ;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Belgium; Germany; France; United Kingdom;

Has the same GMO been notified elsewhere by the same notifier?
Yes

If yes, notification number(s):


GMO characterization

GMO is a:
Other: mammals

Identity of the GMO:
Genus: Human
Species: Homo Sapiens


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
12/05/2020 00:00:00
Remarks: